NIH-funded research R21 grant

Creating affordable contrast agents for advanced imaging techniques

Official title: Rapid low-cost production of contrast agents for metabolic imaging

Funded at Wayne State University · NIH-10893309 · Data updated 2026-11-12

This study is working on a new way to make special dyes for PET scans that can help doctors see important details about your health, like detecting cancer, more quickly and safely, so you can get better results in less time.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$218,771
NIH project number5R21EB033872-02
Project IDNIH-10893309 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients undergoing PET scans for cancer diagnosis or treatment monitoring.

Less likely to help

Patients who are not undergoing imaging procedures or those with conditions that do not require metabolic imaging may not benefit from this research.

What this research studies

This research focuses on developing a new method for producing contrast agents used in metabolic imaging, specifically for Positron Emission Tomography (PET) scans. By utilizing hyperpolarization techniques, the study aims to enhance the detection of low-concentration metabolites in real-time, significantly reducing the time and radiation exposure associated with traditional imaging methods. Patients will benefit from faster scans and improved diagnostic accuracy for conditions like cancer. The research is being conducted at Wayne State University in Detroit.

Why it matters

Potential benefit: If successful, this research could lead to quicker and safer imaging procedures for patients, improving the diagnosis and monitoring of serious diseases.

How similar studies have gone: Previous research has shown promise in using hyperpolarized agents for imaging, indicating a potential for success in this novel approach.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Chekmenev, Eduard — Wayne State University
  • Study coordinator: Chekmenev, Eduard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.